[go: up one dir, main page]

ATE259644T1 - Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd - Google Patents

Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd

Info

Publication number
ATE259644T1
ATE259644T1 AT98929821T AT98929821T ATE259644T1 AT E259644 T1 ATE259644 T1 AT E259644T1 AT 98929821 T AT98929821 T AT 98929821T AT 98929821 T AT98929821 T AT 98929821T AT E259644 T1 ATE259644 T1 AT E259644T1
Authority
AT
Austria
Prior art keywords
hemoglobin
treatment
nitrogen oxide
erythrocytes
containing hemoglobin
Prior art date
Application number
AT98929821T
Other languages
English (en)
Inventor
Takashi Yonetani
Antonio Tsuneshige
Original Assignee
Foryou Corp
Takashi Yonetani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foryou Corp, Takashi Yonetani filed Critical Foryou Corp
Application granted granted Critical
Publication of ATE259644T1 publication Critical patent/ATE259644T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98929821T 1997-07-03 1998-07-03 Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd ATE259644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5168097P 1997-07-03 1997-07-03
PCT/JP1998/003002 WO1999001146A1 (en) 1997-07-03 1998-07-03 Treatment of hemoglobin containing erythrocytes with nitric oxide

Publications (1)

Publication Number Publication Date
ATE259644T1 true ATE259644T1 (de) 2004-03-15

Family

ID=21972754

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98929821T ATE259644T1 (de) 1997-07-03 1998-07-03 Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd

Country Status (7)

Country Link
US (1) US6087087A (de)
EP (1) EP0948337B1 (de)
JP (1) JP3568541B2 (de)
AT (1) ATE259644T1 (de)
CA (1) CA2264792A1 (de)
DE (1) DE69821740T2 (de)
WO (1) WO1999001146A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2381205C (en) * 1999-08-02 2010-05-11 Duke University Method for determining physiological effects of hemoglobin
US20030228564A1 (en) * 2001-05-30 2003-12-11 Edrich Richard Alan Nitric oxide in a pathogen inactivation process
WO2003057380A2 (en) * 2002-01-11 2003-07-17 Whitlock David R Compositions including ammonia oxidizing bacteria and methods of using same
US20060088942A1 (en) * 2002-05-29 2006-04-27 Stamler Jonathan S Measuring nitric oxide in blood gases and treatments based thereon
WO2004054433A2 (en) * 2002-12-12 2004-07-01 Duke University Forming iron nitrosyl hemoglobin
BRPI0414813A (pt) * 2003-09-26 2006-11-14 David R Whitlock método para o uso de bactéria que oxidam a amÈnia
WO2005072773A1 (ja) * 2004-01-29 2005-08-11 Keio University 赤血球機能修飾物質
AU2006220548B2 (en) 2005-03-07 2011-04-21 Sangart, Inc. Composition and methods for delivering carbon monoxide (CO) and nitric ozide (NO) CO to tissue using heme proteins as carriers
US9199026B2 (en) * 2011-01-07 2015-12-01 Somerset Group Enterprises, Inc. Modular extracorporeal systems and methods for treating blood-borne diseases
AU2012228972A1 (en) 2011-03-16 2013-10-24 Dynasil Biomedical Corporation Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations
JP6389125B2 (ja) * 2011-11-07 2018-09-12 ザ ジェネラル ホスピタル コーポレイション 赤血球の処理法
CA2897426A1 (en) 2012-01-09 2013-07-18 Somerset Group Enterprises, Inc. Modular extracorporeal systems and methods for treating blood-borne diseases
GB201207543D0 (en) * 2012-05-01 2012-06-13 Haemair Ltd Treatment of transfusion blood
EP2961269B1 (de) * 2013-02-28 2021-09-15 Hemanext Inc. Vorrichtung zur gasabreicherung für blutprodukte
WO2015179602A1 (en) * 2014-05-21 2015-11-26 Albert Einstein College Of Medicine, Inc. Compositions and methods for enhancing red blood cell storage time and survivability using nitric oxide releasing hybrid hydrogel nanoparticles
US10744261B2 (en) 2015-09-25 2020-08-18 Sanmina Corporation System and method of a biosensor for detection of vasodilation
US10952682B2 (en) 2015-07-19 2021-03-23 Sanmina Corporation System and method of a biosensor for detection of health parameters
US10932727B2 (en) 2015-09-25 2021-03-02 Sanmina Corporation System and method for health monitoring including a user device and biosensor
US10321860B2 (en) 2015-07-19 2019-06-18 Sanmina Corporation System and method for glucose monitoring
US10194871B2 (en) 2015-09-25 2019-02-05 Sanmina Corporation Vehicular health monitoring system and method
US9636457B2 (en) 2015-07-19 2017-05-02 Sanmina Corporation System and method for a drug delivery and biosensor patch
US10750981B2 (en) 2015-09-25 2020-08-25 Sanmina Corporation System and method for health monitoring including a remote device
US9788767B1 (en) 2015-09-25 2017-10-17 Sanmina Corporation System and method for monitoring nitric oxide levels using a non-invasive, multi-band biosensor
US10973470B2 (en) 2015-07-19 2021-04-13 Sanmina Corporation System and method for screening and prediction of severity of infection
US10888280B2 (en) 2016-09-24 2021-01-12 Sanmina Corporation System and method for obtaining health data using a neural network
US10736580B2 (en) 2016-09-24 2020-08-11 Sanmina Corporation System and method of a biosensor for detection of microvascular responses
US10945676B2 (en) 2015-09-25 2021-03-16 Sanmina Corporation System and method for blood typing using PPG technology
US10466783B2 (en) 2018-03-15 2019-11-05 Sanmina Corporation System and method for motion detection using a PPG sensor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ249176A (en) * 1992-02-07 1996-11-26 Vasogen Inc Method of increasing concentration of nitric oxide in blood using ozone and uv radiation
US6197745B1 (en) * 1995-09-15 2001-03-06 Duke University Methods for producing nitrosated hemoglobins and therapeutic uses therefor
EP1015490B1 (de) * 1997-02-06 2004-04-14 Duke University Unmodifizierte hämoglobine und deren verwendung

Also Published As

Publication number Publication date
EP0948337B1 (de) 2004-02-18
JP2001507375A (ja) 2001-06-05
DE69821740T2 (de) 2005-03-17
JP3568541B2 (ja) 2004-09-22
DE69821740D1 (de) 2004-03-25
WO1999001146A1 (en) 1999-01-14
EP0948337A1 (de) 1999-10-13
US6087087A (en) 2000-07-11
CA2264792A1 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
ATE259644T1 (de) Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd
DE69923671D1 (de) Verwendung von kannabidiol als entzündunghemmende mittel
DE69815703D1 (de) Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen
MY113490A (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
DE69733826D1 (de) Behandlung von leukocyten durch photopheresis
DE69328777D1 (de) Dekontaminierung von Plättchen mit 8-Methoxypsoralen
BR9910251A (pt) Estimulação hematopoiética
ATE287210T1 (de) Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen
EP0277428A3 (de) Kosmetische Zusammensetzung
ATE220920T1 (de) Stickstoffoxydabgebendes präparat zur reduzierung der toxizität von wirkstoffen
ATE187335T1 (de) Verwendung von diätetischen molkeproteinen zur behandlung von hiv seropositiven individuen
ATE70450T1 (de) Zusammensetzungen aus vanadium und peroxyd als nachahmungsmittel von insulin.
ES2037669T3 (es) Un procedimiento para preparar una sustancia que se une a la trombina.
ATE421319T1 (de) Mit s-nitrosothiol angereicherte erythrocyten und deren verwendung
NO994330L (no) Metode for behandling av en tumor
DE60336187D1 (de) Verwendung von einem Extrakt von einem nicht-photosynthetischen faserigen Bakterium zur Beförderung der Herstellung von Superoxid-dismutase
AU2003212300A1 (en) Use of one or more natural or modified oxygen carriers, devoid of plasma and cellular membrane constituents, for externally treating open, in particular chronic wounds
DE69725882D1 (de) Adenovirus e4 proteine für induktion von zelltod
ATE207932T1 (de) Komplexe aus porphyrin und menschlichem serumalbumin mit der fähigkeit, sauerstoff zu binden, und deren therapeutische verwendungen
ATE201823T1 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
DE69903559D1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
ATE59781T1 (de) Potenzierung von prazosin.
WO2000002580A3 (en) Therapies using hemoproteins
ATE227125T1 (de) Behandlung und prophylaxe von unerwünschten effekten reaktiver sauerstoffverbindungen
ATE140389T1 (de) Hämoglobin-oligomer basierte komposition und seine herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties